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1. The Burden of Chronic Pain
Chronic pain is a significant public health burden. This
affliction affects at least 10 percent of the world’s population with an additional 10 percent developing various
forms of debilitating chronic pain every year (1). The 2010
global burden of disease report places back pain as the
leading cause of years lost to disability (2). Upon further
review of this report, it becomes apparent that eight of the
top 12 conditions responsible for global disability, which
include low back pain, neck pain, arthritis, other musculoskeletal conditions, migraines, anxiety, depression, and
drug use disorder, are conditions associated with chronic
pain.
The Department of Health and Human Services (HHS),
National Institutes of Health (NIH) requested the Institute
of Medicine (IOM) to address the current state of pain research, care, and education and to explore and make recommendations for the advancement of the science related
to the field. The IOM report released in 2011 estimates that
approximately 100 million suffer from chronic pain (3). Admittedly, the number of people actively seeking care for
this complex disease does not reach 100 million. However, many people live with the burden of chronic pain,
which may wax or wane during their lifetimes. According
to various estimates, 20 - 30 million individuals experience
chronic pain to such a degree that it erodes quality of life
and the ability to work while forcing them to actively seek
care for this condition. Access to providers with the skills
necessary for appropriate evaluation and management of
pain is limited. The majority of sufferers seek care with
their primary care providers, many of whom are primarily
in a rural setting in the state of Kansas. These providers often lack the additional resources needed for the appropri-

ate evaluation and management of chronic pain patients
presenting with complex behavioral manifestations and
functional limitations. Without the proper care, patients
are unable to break out of the vicious cycle of increasing
pain, limited function, and generalized deconditioning.

2. CDC Guidelines for the Prescription of Opioids for
Persistent Non-Cancer Pain
Juxtaposed against this scourge of pain is the epidemic
of opioid abuse. Deaths related to the abuse of prescription and non-prescription opioids reached a new crest in
2014 with 165,000 fatalities, the highest rates of overdose
among people aged 25 - 54 years (4). It will come as no
surprise that the sales of prescription opioids have also
quadrupled from 1999 - 2012 (5). Whereas prior to the
2000s it was widely believed that risk of addiction was low
in chronic pain populations, recent data has revealed that
as many as 1 in 4 individuals treated with prescription opioids for long term non-cancer pain in primary care settings may struggle with addiction (6). In light of these
concerns, the Centers for Disease Control (CDC) released
guidelines for the prescription of opioids for persistent
non-cancer pain (Table 1) (7). Many of the proposed guidelines promote the development of a treatment plan with a
stepped up approach to opioid therapy, i.e., the exploration
of alternatives and attempts at ensuring compliance and
utilization of available prescription monitoring resources.
However, some controversial approaches may lead to the
unintentional consequence of reduced patient access to
providers while still giving patients access to medications
that allow them to maintain some quality of life and reasonable function.
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Table 1. CDC Recommendations for Prescribing Opioids for Chronic Pain Outside Active Cancer, Palliative, and End-of-Life Carea

Determining When to Initiate or Continue Opioids for Chronic Pain
1. Nonpharmacologic therapy and nonopioid pharmacologic therapy are preferred for chronic pain. Clinicians should consider opioid therapy only if expected
benefits for both pain and function are anticipated to outweigh risks to the patient. If opioids are used, they should be combined with nonpharmacologic
therapy and nonopioid pharmacologic therapy, as appropriate.
2. Before starting opioid therapy for chronic pain, clinicians should establish treatment goals with all patients, including realistic goals for pain and function,
and should consider how therapy will be discontinued if benefits do not outweigh risks. Clinicians should continue opioid therapy only if there is clinically
meaningful improvement in pain and function that outweighs risks to patient safety.
3. Before starting and periodically during opioid therapy, clinicians should discuss with patients known risks and realistic benefits of opioid therapy and patient
and clinician responsibilities for managing therapy.
Opioid Selection, Dosage, Duration, Follow-Up, and Discontinuation
4. When starting opioid therapy for chronic pain, clinicians should prescribe immediate-release opioids instead of extended-release/long-acting (ER/LA) opioids.
5. When opioids are started, clinicians should prescribe the lowest effective dosage. Clinicians should use caution when prescribing opioids at any dosage,
should carefully reassess evidence of individual benefits and risks when increasing dosage to ≥ 50 morphine milligram equivalents (MME)/day, and should
avoid increasing dosage to ≥ 90 MME/day or carefully justify a decision to titrate dosage to ≥ 90 MME/day.
6. Long-term opioid use often begins with treatment of acute pain. When opioids are used for acute pain, clinicians should prescribe the lowest effective dose of
immediate-release opioids and should prescribe no greater quantity than needed for the expected duration of pain severe enough to require opioids. Three days
or less will often be sufficient; more than seven days will rarely be needed.
7. Clinicians should evaluate benefits and harms with patients within 1 to 4 weeks of starting opioid therapy for chronic pain or of dose escalation. Clinicians
should evaluate benefits and harms of continued therapy with patients every 3 months or more frequently. If benefits do not outweigh harms of continued
opioid therapy, clinicians should optimize other therapies and work with patients to taper opioids to lower dosages or to taper and discontinue opioids.
Assessing Risk and Addressing Harms of Opioid Use
8. Before starting and periodically during continuation of opioid therapy, clinicians should evaluate risk factors for opioid-related harms. Clinicians should
incorporate into the management plan strategies to mitigate risk, including considering offering naloxone when factors that increase risk for opioid overdose,
such as history of overdose, history of substance use disorder, higher opioid dosages (≥ 50 MME/day), or concurrent benzodiazepine use, are present.
9. Clinicians should review the patient’s history of controlled substance prescriptions using state prescription drug monitoring program (PDMP) data to
determine whether the patient is receiving opioid dosages or dangerous combinations that put him or her at high risk for overdose. Clinicians should review
PDMP data when starting opioid therapy for chronic pain and periodically during opioid therapy for chronic pain, ranging from every prescription to every 3
months.
10. When prescribing opioids for chronic pain, clinicians should use urine drug testing before starting opioid therapy and consider urine drug testing at least
annually to assess for prescribed medications as well as other controlled prescription drugs and illicit drugs.
11. Clinicians should avoid prescribing opioid pain medication and benzodiazepines concurrently whenever possible.
12. Clinicians should offer or arrange evidence-based treatment (usually medication-assisted treatment with buprenorphine or methadone in combination with
behavioral therapies) for patients with opioid use disorder.
a

All recommendations are category A (apply to all patients outside of active cancer treatment, palliative care, and end-of-life care) except recommendation 10 (designated
category B, with individual decision making required); see full guideline for evidence ratings.

3. National Pain Strategy
Recognizing the burden of chronic pain, the US
congress provided a mandate to the NIH to evaluate and
make recommendations “to increase the recognition of
pain as a significant public health problem in the United
States” (8). The NIH contracted with the IOM, which developed a report calling for the development of a comprehensive population health-level strategy to lead a cultural
transformation in pain prevention, care, education, and
research (3). The National Pain Strategy is the result of
HHS requesting the Interagency Pain Research Coordinating Committee (IPRCC) to oversee the development of such
a strategy. The National Pain Strategy provides a focus on
six key areas:
- Population research
2

- Prevention and care
- Addressing disparities in care
- Service delivery and reimbursement
- Professional education and training
- Public education and communication
Through this broad focus, the National Pain Strategy
envisions a decrease in the incidence and prevalence of
acute, chronic pain across the life span from pediatric
through geriatric populations, including end-of-life care.
Those suffering pain would receive timely access to comprehensive care tailored to their biological, psychological,
and social needs based upon evidence and efficacy delivered in a patient-centric manner. Chronic pain is a complex disease and a significant public health burden, therefore considerable efforts need to focus on recognition of
risk factors as well as mitigation, prevention, and selfAnesth Pain Med. 2017; 7(1):e40951.
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management strategies.
This bold vision will need champions at the national,
regional, state, and local levels. Disparities in care, in areas such as population research, may require large coordinated research infrastructures. Public and professional education, on the other hand, could be accomplished through the efforts of small groups working together toward the aims of better care for chronic pain
patients through prevention, comprehensive assessment,
and evidence-based interdisciplinary care. Outlined below
are some efforts at the local and regional level in the state
of Kansas.

4. Kansas Partnership for Pain Management
The Kansas partnership for pain management is a multidisciplinary group comprised of individuals from family medicine, anesthesiology/pain medicine, psychology,
emergency medicine, pathology, psychiatry, nursing, education, pharmacy, chiropractic groups, bioethics, and
various state and federal agencies that studied Kansas
healthcare provider and Kansas healthcare related agency
concerns regarding the assessment and management of
chronic pain. This assessment revealed almost unanimous concern regarding the need for pain management
education. A comprehensive statewide, multi-year, multitiered collaboration aimed at improving practice performance for the assessment and management of chronic
pain was developed. The program envisioned an inaugural statewide foundational conference followed by 1 - 2 day
primary care intensives and quality/performance improvement (QI) projects at the practice level. The first phase
of the plan was completed with a conference in Wichita,
Kansas, in November 2014. Attendance was excellent with a
diverse group of 265 healthcare providers. The conference
utilized patient interviews, discussions, role play, video vignettes, and case presentations. Ninety-five percent of attendees strongly agreed that course objectives were met.
The group is now focused on planning the next stages of
pain education in the form of intensives in two additional
areas in the state of Kansas. The intensives will include recruitment of primary care practices in the target areas, a
lecture program reviewing the foundational elements of
pain assessment and management, and the development
of online modules for pain-related quality improvement
projects at the practice level (9).

5. Project ECHO Kansas
Chronic pain is a complex disease. Patients suffering
from pain need access to specialty care and education for
Anesth Pain Med. 2017; 7(1):e40951.

this complex health condition. Unfortunately, there are
not enough specialists in the field of pain management to
provide care for everyone who suffers from pain, especially
in rural and underserved communities. Project ECHO is
a learning and guided practice model that seeks to empower and educate providers in remote areas through a
hub-and-spoke knowledge-sharing network led by experts
through multi-point videoconferencing (10). Many different versions of project ECHO exist around the country and
focus on various chronic diseases, one of which is chronic
pain. The Kansas project ECHO for chronic pain is in the pilot stage. The goal is to reach a select group of primary care
practices scattered across the state and utilize the ECHO
model to enhance practice knowledge of the assessment
and management of chronic pain, provide teleconference
access to experts in the field, and to assist them in developing staged quality improvement projects to achieve the
aims of improvement in the management of the patient in
pain.

6. Conclusion
Pain is one of the most common reasons for seeking
medical care. Many Kansans will experience pain during the course of their lives; some will go on to develop
chronic debilitating pain. The appropriate use of opioids
will likely continue to be a widely used modality along a
spectrum of other treatment options ranging from selfmanagement techniques, other pharmacological agents,
functional and psychological rehabilitation, various surgical and minimally invasive interventions, and complementary and alternative options to advanced pain techniques.
While the national pain strategy aims to shed more light
on the public health crisis of pain as a disease, the CDC
guidelines may result in the unanticipated consequence
of reduced access to primary care providers who are willing to explore appropriate opioid therapy for the right patient at the right time for the right reasons after other
modalities have been considered and patient and provider
goals have been discussed. Thus patients find themselves
caught between a rock and a hard place. Those who had
been able to maintain meaningful lives through the responsible use of opioids, after exhaustion of other options,
are being tapered off their medications or encouraged to
find another provider willing to take over these prescriptions. It is through the education of patients, providers,
and healthcare organizations that we will be able to better
navigate the turbulent waters of the recognition of pain as
a complex biopsychosocial disease requiring the appropriate treatment. This task will include balancing the appropriate utilization of opioids, when and if necessary, to curb
3
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and ultimately eliminate fatalities related to overdoses of
this class of medication.
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